Sangamo Therapeutics Statistics
Total Valuation
SGMO has a market cap or net worth of $167.81 million. The enterprise value is $156.46 million.
Important Dates
The next confirmed earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMO has 224.71 million shares outstanding. The number of shares has increased by 15.62% in one year.
| Current Share Class | 224.71M |
| Shares Outstanding | 224.71M |
| Shares Change (YoY) | +15.62% |
| Shares Change (QoQ) | -1.93% |
| Owned by Insiders (%) | 1.32% |
| Owned by Institutions (%) | 27.86% |
| Float | 218.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.44 |
| Forward PS | 1.72 |
| PB Ratio | 6.55 |
| P/TBV Ratio | 7.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.34.
| Current Ratio | 1.13 |
| Quick Ratio | 1.02 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -185.39% and return on invested capital (ROIC) is -70.52%.
| Return on Equity (ROE) | -185.39% |
| Return on Assets (ROA) | -46.05% |
| Return on Invested Capital (ROIC) | -70.52% |
| Return on Capital Employed (ROCE) | -176.16% |
| Revenue Per Employee | $315,847 |
| Profits Per Employee | -$535,197 |
| Employee Count | 183 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -167,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.03% in the last 52 weeks. The beta is 1.46, so SGMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +33.03% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 50.45 |
| Average Volume (20 Days) | 4,292,819 |
Short Selling Information
The latest short interest is 28.25 million, so 12.57% of the outstanding shares have been sold short.
| Short Interest | 28.25M |
| Short Previous Month | 29.71M |
| Short % of Shares Out | 12.57% |
| Short % of Float | 12.93% |
| Short Ratio (days to cover) | 2.60 |
Income Statement
In the last 12 months, SGMO had revenue of $57.80 million and -$97.94 million in losses. Loss per share was -$0.49.
| Revenue | 57.80M |
| Gross Profit | -53.72M |
| Operating Income | -98.35M |
| Pretax Income | -248.51M |
| Net Income | -97.94M |
| EBITDA | -93.24M |
| EBIT | -98.35M |
| Loss Per Share | -$0.49 |
Full Income StatementBalance Sheet
The company has $41.92 million in cash and $30.57 million in debt, giving a net cash position of $11.35 million or $0.05 per share.
| Cash & Cash Equivalents | 41.92M |
| Total Debt | 30.57M |
| Net Cash | 11.35M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 22.77M |
| Book Value Per Share | 0.11 |
| Working Capital | 5.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$67.14 million and capital expenditures -$267,000, giving a free cash flow of -$67.41 million.
| Operating Cash Flow | -67.14M |
| Capital Expenditures | -267,000 |
| Free Cash Flow | -67.41M |
| FCF Per Share | -$0.30 |
Full Cash Flow StatementMargins
Gross margin is -92.94%, with operating and profit margins of -170.15% and -169.45%.
| Gross Margin | -92.94% |
| Operating Margin | -170.15% |
| Pretax Margin | -169.74% |
| Profit Margin | -169.45% |
| EBITDA Margin | -161.32% |
| EBIT Margin | -170.15% |
| FCF Margin | n/a |
Dividends & Yields
SGMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.62% |
| Shareholder Yield | -15.62% |
| Earnings Yield | -58.36% |
| FCF Yield | -40.17% |
Analyst Forecast
The average price target for SGMO is $5.17, which is 592.29% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.17 |
| Price Target Difference | 592.29% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 42.25% |
| EPS Growth Forecast (5Y) | -30.00% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGMO has an Altman Z-Score of -21.79 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.79 |
| Piotroski F-Score | 1 |